Robert Wilbur, Pharm.D., CPh. | Executive Director, Medical Affairs

Robert received his Bachelors of Science degree from the University of South Florida, Doctorate of Pharmacy degree from Mercer University, and completed a Clinical Residency at Emory University.

Through his 27 years in the profession of pharmacy, Robert has been involved in almost every facet of the industry. He has served as the Chief Clinical Pharmacist for a large metropolitan hospital, conducted clinical drug trials, consulted for three international pharmaceutical companies, and was a Vice President for an international healthcare company.

Robert is now the Executive Director of Medical Affairs for Gensco Laboratories.

Return to Gensco Leadership Team Page »



A single dose topical colchinium for acute gout flares.


A single dose topical anesthetic for injections and vaccines.


Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in development and commercialization of prescription more...

Looking To The Future

A single dose topical colchinium for acute gout flares.